BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03504163-completion@plaintrial.com
DTSTAMP:20261028T143954Z
DTSTART;VALUE=DATE:202604
SUMMARY:Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as Firs
 t-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIB
 C) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NM
 I-UTUC)] — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03504163
URL:https://plaintrial.com/trial/NCT03504163
END:VEVENT
END:VCALENDAR